Pizotifen
- TRADE NAMES: Sandomigran; Sanmigran; Sanomigran (Novartis)
- INDICATIONS: Recurrent vascular headaches, including classical migraine, common migraine and cluster headaches
- CLASS: 5-Hydroxytryptamine antagonist
- HALF-LIFE: 23 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adrenergic neurone blockers , Alcohol, Antihistamines, Butalbital, Hypnotics, Isocarboxazid, Pentobarbital, Phenelzine, Phenobarbital, Primidone, Sedatives, Tranylcypromine, Zolpidem
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
